
Safronac 200mg Tablet SR
Marketer
Saffron Therapeutics Pvt Ltd
Salt Composition
Aceclofenac (200mg)
Overview Safronac 200mg Tablet SR
Arthritis relief is provided by the extended-release Safronac 200mg tablet. This medication effectively reduces pain and inflammation associated with conditions such as rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis. Dosage and treatment duration for Safronac 200mg Tablet SR should always follow your physician's instructions. Administering it with food or milk minimizes potential stomach irritation. Potential side effects may include nausea, diarrhea, dizziness, abdominal discomfort, indigestion, and elevated liver enzymes. For extended therapy, your doctor might monitor your liver and kidney function, along with blood counts. Prolonged use carries a risk of serious complications, including gastrointestinal bleeding and kidney dysfunction.
Uses of Safronac 200mg Tablet SR
Analgesia
Major Benefits of Safronac 200mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Safronac 200mg Tablet SR should be administered with a meal.
Common Side effects of Safronac 200mg Tablet SR:
- Dizziness
- Indigestion
- Nausea
- Abdominal pain
- Increased liver enzymes
How to use Safronac 200mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Safronac 200mg Tablet SR whole; do not break, crush, or chew it. Administer this medication with food.
How Safronac 200mg Tablet SR works:
Safronac 200mg Extended-Release Tablets are a non-steroidal anti-inflammatory drug (NSAID) that inhibits the production of inflammatory mediators responsible for pain and associated swelling and redness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Safronac 200mg Tablet SR and alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The extended-release Safronac 200mg tablet may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to the unborn. A physician will assess the potential advantages against any risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Safronac 200mg sustained-release tablets while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking a Safronac 200mg sustained-release tablet could reduce alertness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if such effects are experienced.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Safronac 200mg SR tablets, as dose modification may be necessary. Consult a physician for guidance. Safronac 200mg SR tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Safronac 200mg sustained-release tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Safronac 200mg sustained-release tablets are contraindicated in individuals with severe hepatic dysfunction. Close monitoring of liver function is recommended during treatment.
What if you forget to take Safronac 200mg Tablet SR :
Should you forget a Safronac 200mg Tablet SR dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Safronac 200mg Tablet SR
| Label | Value |
|---|---|
| Chemical Type | Dichlorobenzene Derivative |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
| Action Category | Nonselective COX-1 and COX-2 inhibitors (acetic acid derivatives) |
